-
Dabigatran Assays: Workflow, Insights, and Troubleshooting
2026-09-04
Build more informative thrombin inhibition assays with Dabigatran by combining concentration-response testing, orthogonal coagulation readouts, and metabolite-aware interpretation. This workflow translates Pradaxa-related pharmacology into practical research decisions for thrombosis, coagulation, and anticoagulant development studies.
-
Imatinib (STI571): From Kinase Maps to Translation
2026-09-04
A translational framework for using Imatinib (STI571) as a causal probe of Abl, PDGF receptor, and c-Kit signaling while integrating pathway assays, advanced tumor models, and spatial mass spectrometry imaging.
-
Norepinephrine bitartrate: Applied Research Workflows
2026-09-03
Build more reproducible adrenergic signaling, cardiomyopathy, and hemodynamic assays with a workflow that separates receptor biology from formulation effects. Practical handling, salt-to-base reporting, and troubleshooting guidance help translate (-)-Norepinephrine (+)-bitartrate data across in vitro and animal studies.
-
DiscoveryProbe Stem Cell Compound Library Plus Workflow
2026-09-03
Turn pathway coverage into interpretable stem cell phenotypes with a 280-compound collection spanning self-renewal, differentiation, and disease-relevant signaling. This workflow combines high-content imaging, orthogonal validation, and the schistosome stem-cell screening model to improve hit triage while reducing false positives from general toxicity.
-
Sulfisomidine Workflows for Enzyme and Microbial Research
2026-09-02
Sulfisomidine, also indexed as sulfamethin, connects antibacterial metabolism studies with quantitative hPON1 inhibition assays. This practical guide covers stock preparation, mixed-type enzyme kinetics, microbial screening, environmental transformation workflows, and troubleshooting for reproducible results.
-
LLC-PK1/MDR1 Model for BBB Permeability Prediction
2026-09-02
Hu et al. developed a high-throughput surrogate blood-brain barrier model by combining LLC-PK1-MOCK and LLC-PK1-MDR1 Transwell systems with a correction for lysosomal drug trapping. The study links in vitro permeability with unbound brain distribution and provides a practical framework for separating passive diffusion, P-glycoprotein efflux, and intracellular sequestration during early CNS drug screening.
-
AO/PI Staining Solution for Diabetic Nephropathy
2026-09-01
Translate diabetic nephropathy mechanism studies into cleaner viability measurements with dual fluorescent DNA dyes. AO/PI Staining Solution supports live dead cell discrimination, impurity exclusion, and reproducible fluorescence-based cell counting in podocyte and primary-cell workflows.
-
Lithium, Exosomal Wnt10a, and Bone Regeneration
2026-09-01
The 2024 ACS Applied Materials & Interfaces study identifies a mechanism by which lithium enhances osteogenesis: MARK2-dependent Rab11a/Rab11FIP1 trafficking increases exosomal Wnt10a secretion, activating β-catenin signaling in bone mesenchymal stem cells. Its comparison of lithium-conditioned exosomes and GelMA hydrogels provides a mechanistic and biomaterials framework for improving bone repair, while also highlighting the need for pathway-specific validation in future studies.
-
CTOP: A Causal Tool for μ-Opioid Circuit Research
2026-08-31
CTOP is a selective μ-opioid receptor antagonist for separating receptor-level causality from circuit-level observations. This guide connects CTOP pharmacology with recent findings on mechanical opioid hypersensitivity and provides a rigorous framework for binding, signaling, and pain mechanism research.
-
CTOP for μ-Opioid Receptor Signaling Studies
2026-08-31
CTOP provides a selective pharmacological way to test whether μ-opioid receptor activation drives cellular signaling, mechanical hypersensitivity, or opioid tolerance. This workflow connects receptor-level assays with the brain-to-spinal circuit identified in recent mouse pain research while emphasizing route controls, timing, and interpretation.
-
dhcr7 Knockout Grass Carp Shows GCRV Resistance
2026-08-30
A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and found substantially improved survival after GCRV-II challenge, together with stronger antiviral responses and reduced tissue damage. The results provide in vivo evidence that cholesterol biosynthesis can influence antiviral defense and identify dhcr7 as a candidate target for disease-resistant aquaculture breeding.
-
Ampicillin Sodium: Mechanism and Research Benchmarks
2026-08-29
Ampicillin sodium is a β-lactam antibiotic used to study bacterial cell wall biosynthesis inhibition. Vendor-reported benchmarks include a transpeptidase IC50 of 1.8 μg/mL and an MIC of 3.1 μg/mL, but assay conditions should be confirmed before comparison across experiments.
-
DiscoveryProbe Stem Cell Compound Library Plus
2026-08-28
DiscoveryProbe Stem Cell Compound Library Plus supports mechanism-guided stem cell pathway profiling and high-content phenotypic screening. This article shows how quantitative cell-state readouts, pathway coverage, and orthogonal validation can convert a broad compound screen into defensible assay decisions.
-
Foretinib, ICD, and Anti-CD47 Therapy in Colorectal Cancer
2026-08-28
The reference study identifies foretinib as an inducer of immunogenic cell death in colorectal cancer, linking c-Met/VEGFR2 inhibition to p53–DR5 signaling, DAMP release, and immune activation. Its combination with anti-CD47 immunotherapy suggests a complementary strategy that couples tumor-cell killing with improved antitumor immune recognition.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-08-27
HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) provides an enzyme-labeled secondary reagent for detecting mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be used as a default secondary for non-mouse or non-IgG primaries, fluorescent workflows, or assays that are incompatible with HRP substrates.